RPT-Tiny stem cell companies close in on major heart disease goals
December 18, 2017 at 07:00 AM EST
NEW YORK, Dec 18 (Reuters) - The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.